Literature DB >> 12165878

CEA and survival in patients with stage IA-B NSCLC.

H Ishikawa1, H Satoh, Y T Yamashita, M Ohtsuka, K Sekizawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12165878     DOI： 10.1055/s-2002-33098

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN： 0171-6425            Impact factor:   1.827


× No keyword cloud information.
  2 in total

1.  Ultrasonic diagnosis combined with targeted ultrasound contrast agent improves diagnostic sensitivity of ultrasonic for non-small cell lung cancer patients.

Authors:  Xiaohong Zhang; Can Xiao
Journal:  Exp Ther Med       Date:  2018-05-23       Impact factor: 2.447

2.  Serum CEA and CYFRA Levels in ALK-rearranged NSCLC Patients: Correlation With Distant Metastasis.

Authors:  Takeshi Numata; Takeo Endo; Hidetoshi Yanai; Kyoko Ota; Yusuke Yamamoto; Kei Shimizu; Hideyasu Yamada; Kenji Hayashihara; Shinichiro Okauchi; Hiroaki Satoh; Yutaka Yamada; Tomohiro Tamura; Kazuto Saito; Norihiro Kikuchi; Koichi Kurishima; Hiroichi Ishikawa; Hiroko Watanabe; Toshihiro Shiozawa; Nobuyuki Hizawa; Yasunori Funayama; Shigen Hayashi; Hiroyuki Nakamura; Takaaki Yamashita
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.